Related Experiment Videos
Use of transvenous DDD pacing in a one-year-old with symptomatic hypertrophic cardiomyopathy
J K Park1, M D Parrish, M E Pollock
1Department of Pediatrics, University of California at Davis School of Medicine, Sacramento 95817, USA.
Insights
Symptomatic hypertrophic cardiomyopathy (HCM) is uncommon in infants. Dual chamber pacing offers a potential alternative to surgery for these young patients with HCM.
Area of Science:
- Pediatric Cardiology
- Cardiovascular Physiology
Background:
- Symptomatic hypertrophic cardiomyopathy (HCM) in infants presents limited therapeutic options.
- Current treatments include medications (beta-blockers, calcium-channel blockers) or surgical myotomy/myectomy.
- Atrioventricular sequential pacing is an established alternative for adult HCM patients.
Observation:
- This study reports the use of transvenous dual chamber pacing in an infant with symptomatic HCM.
- The infant presented with symptoms indicative of significant obstruction and cardiac dysfunction.
Findings:
- Transvenous dual chamber pacing was successfully implemented in the infant patient.
- The procedure aimed to alleviate symptoms associated with hypertrophic cardiomyopathy.
Implications:
- Dual chamber pacing may represent a viable, less invasive therapeutic strategy for infants with symptomatic HCM.
- Further research is warranted to establish the long-term efficacy and safety of this approach in pediatric populations.
- This case highlights innovative management for a rare pediatric cardiac condition.
Abstract:
Symptomatic hypertrophic cardiomyopathy (HCM) is rare in infants. Therapeutic options are limited and include beta-blocker or calcium-channel blocker therapy or surgical myotomy/myectomy. Atrioventricular sequential pacing has been utilized as an alternative to surgery in symptomatic adults with HCM. We report our results with transvenous dual chamber pacing in an infant with symptomatic HCM.